A Phase I Clinical Trial to Evaluate CU-10101 Unguent
Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-09-09
Target enrollment:
Participant gender:
Summary
The study was conducted in two parts:Part 1 and Part 2.Part 1 is a single-site,randomized,double-blind,vehicle-controlled single and multiple administration,dose-escalation study in healthy Chinese participants.There are four cohorts in Part 1.Part 2 is a randomized,double-blind,vehicle-controlled single and multiple administration,dose-escalation study in Chinese participants with mild to moderate atopic dermatitis.It is planned to be conduct in 1 to 3 sites,with a total of four cohorts in Part 2.